Substituted 1-arylalkyl-4-acylaminopiperidine compounds and methods of producing and using the same
申请人:Arizona Board of Regents on Behalf of the University of Arizona
公开号:US11440885B2
公开(公告)日:2022-09-13
The present invention provides using a substituted 1-arylalkyl-4-acylaminopiperidine compound of Formula I:
to treat various clinical conditions including, but not limited to, hemorrhagic shock, nicotine withdrawal symptoms, gastrointestinal side effects of opioids, cancer therapy, epithelial wounds, herpes zoster infection, or opioid-induced pruritus. In compound of Formula I, R1 is C1-10 alkyl, C1-10 haloalkyl, optionally substituted aryl, or optionally substituted heteroaryl; R2 is C1-6 alkylene; Y is optionally substituted aryl, optionally substituted heteroaryl, or a moiety of the formula —C(═O)—X1, wherein X1 is —OR3 or —NR4R5, where each of R3, R4 and R5 is H or C1-10 alkyl.
本发明提供使用式 I 的取代 1-芳烷基-4-酰氨基哌啶化合物:
来治疗各种临床病症,包括但不限于失血性休克、尼古丁戒断症状、阿片类药物的胃肠道副作用、癌症治疗、上皮伤口、带状疱疹感染或阿片类药物诱发的瘙痒症。在式I化合物中,R1是C1-10烷基、C1-10卤代烷基、任选取代的芳基或任选取代的杂芳基;R2是C1-6亚烷基;Y是任选取代的芳基、任选取代的杂芳基或式-C(═O)-X1的分子,其中X1是-OR3或-NR4R5,其中R3、R4和R5各自是H或C1-10烷基。